#Bpmc price drivers
#Bpmc price full

Stock up in the aftermarket hours, following the news release. Blueprint Medicines (BPMC) announces better-than-expected financial performance in fourth-quarter and full-year 2022.

#Bpmc price full

Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants.Ĭlick Here to get the full Stock Report for Blueprint Medicines Corp stock. HC Wainwright lowered the price target on Blueprint Medicines Corp BPMC. BPMC : 45.08 (+0.20) Blueprint's (BPMC) Q4 Earnings & Sales Top Estimates, Stock Up Zacks - Fri Feb 17, 8:03AM CST.

#Bpmc price drivers

Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Get Fenobucarb at lowest price ID: 23435412155. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. Ghadge Traders - Offering BPMC 50 EC Fenobucarb, 500 Ml,1 Lit at Rs 440.00/litre in Satara, Maharashtra. During the last trading day the stock fluctuated 2.60 from a day low at 49.20 to a day high of 50.48. The average Blueprint Medicines stock price prediction forecasts a potential upside of 51.42 from the current BPMC share price of 49.29. that Blueprint Medicines's share price could reach 74.64 by Aug 7, 2024. Last Price 49.65 Previous Close 49.65 Change 0.00 Open 49. On average, Wall Street analysts predict. BPMC Price, Volume, Earnings, and Dividend Date. Stocks Crypto What We Do Reviews About Us Pricing Sign Up Login. More About Blueprint Medicines Corpīlueprint Medicines Corp is a biopharmaceutical company. For plant production, BPMC uses commercial and conservation nursery price data as a baseline, and then adjusts upwards as previously described. Is BPMC undervalued compared to its fair value, analyst forecasts and its price relative to the market Valuation Score. The Blueprint Medicines Corporation stock price gained 1.14 on the last trading day (Thursday, 31st Aug 2023), rising from 49.30 to 49.86. Thinking about buying or selling stock in BPMC See the latest Blueprint Medicines Corp (BPMC) stock analysis, price, forecast, news and more. To see InvestorsObserver's Sentiment Score for Blueprint Medicines Corp click here. BPMC lost -$9.71 per share in the over the last 12 months.

Over the past year the S&P 500 is up 5.25% while BPMC has gained 2.76%. BPMC has gained $2.22 from the previous closing price of $56.25 on volume of 518,334 shares.

All Rights Reserved.Blueprint Medicines Corp (BPMC) stock is up 3.96% while the S&P 500 is lower by -0.25% as of 12:07 PM on Tuesday, May 23. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. The price has risen in 6 of the last 10 days and is up by 2.68 over the past 2 weeks. While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. Currently, there are 60.13 million shares of Blueprint Medicines Corp stock. During the last market session, Blueprint Medicines Corp’s stock traded between 58.93 and 60.75. Blueprint Medicines Corp is up 5.66 from its previous closing price of 59.74. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. The Blueprint Medicines Corporation stock price gained 1.14 on the last trading day (Thursday, 31st Aug 2023), rising from 49.30 to 49.86. The average of price targets set by Wall Street analysts indicates a potential upside of 61.4 in Blueprint Medicines (BPMC). As of July 28, 2023, 4:00 PM CST, Blueprint Medicines Corp’s stock price was 63.12. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. Get Blueprint Medicines Corp (BPMC. Factset: FactSet Research Systems Inc.2019. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes.